New Imaging based plate reader, the FDSS/µCELL

Article

Hamamatsu introduces a new imaging based plate reader, the FDSS/µCELL; an easy to use, fast and cost-effective solution for compound screening and assay development in the Pharmaceutical and Biotech Industries.

Hamamatsu introduces a new imaging based plate reader, the FDSS/μCELL; an easy to use, fast and cost-effective solution for compound screening and assay development in the Pharmaceutical and Biotech Industries.

The FDSS/μCELL is optimised for fluorescent kinetic assays using calcium and membrane potential dyes such as FLUO4 and FMP.

Dispensing is available in either 96 or 384 well format with exchangeable heads. Agonist / antagonist assays can be performed in the same run and the optional washing system reduces carry over and allows tips to be reused several times.

Based on the renowned FDSS series, the μCELL uses proven and reliable technology. It is equipped with a high-sensitivity Hamamatsu camera that images the entire plate simultaneously to provide fast readout times of a few minutes, compared to the longer readout times offered by conventional scanning based systems.

Designed for fast and simple operation; assay and compound plates can be easily loaded and the assay is ready to start. The software helps you to quickly set assay parameters in a single protocol which can then be easily transferred to the FDSS7000 for further screening.

The FDSS/μCELL is the reader of choice, offering easy set-up and high speed readout for your kinetic assays in fluorescence.

Click here for more information

Contact Details
Freephone Europe: 00 800 800 800 88
Email: europe@hamamatsu.comwww.sales.hamamatsu.com

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content